[Intermittent haemodialysis and HL-A antibody production before and after kidney transplantation (author's transl)].
D000293:Adolescent; D000328:Adult; D000906:Antibodies; D000917:Antibody Formation; D001803:Blood Transfusion; D002648:Child; D005260:Female; D005921:Glomerulonephritis / Q000276:immunology; D006649:Histocompatibility Antigens; D006650:Histocompatibility Testing; D006801:Humans; D007669:Kidney Calculi / Q000276:immunology; D052177:Kidney Diseases, Cystic / Q000276:immunology; D007676:Kidney Failure, Chronic / Q000276:immunology / Q000628:therapy; D016030:Kidney Transplantation; D008213:Lymphocyte Activation; D008233:Lymphotoxin-alpha; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000628:therapy; D011704:Pyelonephritis / Q000276:immunology; D006435:Renal Dialysis; D014019:Tissue Donors; D014184:Transplantation, Homologous
D000906:Antibodies; D006649:Histocompatibility Antigens; D008233:Lymphotoxin-alpha
Chronische dialyse und HL-A Antikörperbildung vor und nach Nierentransplantation